EMBLA · Embla Medical hf
27.20
DKKUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
kr11.83B
PE
25.20
EV/EBITDA
13.6
DIV Yield
0%
Payout Ratio
0%
MQV Rating
2Strong
As at 13/10/2026 12:00:00 AM
Price Chart
Description
- All-Companies
- All-Consensus
- HALO 100
- HALO All
- HALO Earnings Momentum
- HALO Small
Key Fundamentals
EPS 3 yr Growth
91.80%
EBITDA Margin
20.00%
Operating Cashflow
$137m
Free Cash Flow Return
10.40%
ROIC
6.40%
Interest Coverage
8.80
Quick Ratio
0.90
Performance
52 weeks range
Low 25 - 37.9
Trade Value (12mth)
US$95,159.00
1 week
3.95%
1 month
1.84%
YTD
-13.59%
1 year
-10.23%
All time high
57.80
Additional Data
Shares Outstanding (Fully Diluted)
426m
HALO Sector
Healthcare
Next Company Report Date
02-Feb-27
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
USD
Short Sell (% of issue)
0.00
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
Mqv
Strong
Garp
Strong
Mqv Small
Strong
Momentum
Price
Neutral
Earnings
Very Strong
Growth
Earnings
Strong
Dividends
Very Weak
Quality
Capital Efficiency
Neutral
Balance Sheet
Neutral
Valuation
Value
Consensus
Yield
News & Announcements
No announcements available.
Key Stakeholders
| Name | Title |
| William Demant Fonden | Foundation/Endowment |
| Arbejdsmarkedets Tillægspension | Pension Fund |
| Lífeyrissjóður verzlunarmanna | Pension Fund |
| Embla Medical hf | Public Company |
| Niels Jacobsen | Individual |
